This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidermolysis bullosa simplex

Authoring team

Epidermolysis bullosa simplex

Epidermolysis bullosa simplex is caused by a suprabasal split in the epidermis. It is regarded to be the most common form of Epidermolysis bullosa (1).

This form tends to present at the onset of mobility, with blisters occuring on the knees and elbows and progressing to the hands and lower legs. There is no scarring.

Inheritance of this form is autosomal dominant and mutations in the proteins keratin 5 (K5) and keratin 14 (K14) has been recognized as the causative factor (2).

There are three major subtypes of Epidermolysis bullosa simplex:

  • Dowling-Meara variant of EBS (EBS-DM) - is the severest form, seen in a minority of EBS patients with widespread, herpetiform blistering
  • Weber-Cockayne variant of EBS (EBS-WC) - is a milder form, seasonal non-scarring blistering limited to hands and feet can be seen (which is worst in summer months)
  • Köbner form of EBS (EBS-K) - seasonal blisters are seen at sites of friction (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.